Lakefront Biotherapeutics (LKFT) Liabilities and Shareholders Equity (2013 - 2026)
Lakefront Biotherapeutics (LKFT) recorded Liabilities and Shareholders Equity of $3.95 billion in the quarter ended Mar 31, 2026, down 6.7% from $4.23 billion a year earlier and down 0.4% from the prior quarter.
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Lakefront Biotherapeutics reported Liabilities and Shareholders Equity of $3.85 billion, down 14.0% from the prior year.
- Annual Liabilities and Shareholders Equity has declined for six straight years, with a five-year compound annual growth rate of -10.0% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $4.48 billion in the year ended Dec 31, 2024 (-4.5%), $4.69 billion in the year ended Dec 31, 2023 (-6.0%), $4.99 billion in the year ended Dec 31, 2022 (-18.8%) and $6.15 billion in the year ended Dec 31, 2021 (-5.9%).
- The figure for the quarter ended Mar 31, 2026 is the lowest quarterly Liabilities and Shareholders Equity since the quarter ended Jun 30, 2019.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined for three consecutive quarters, with an average decline of 8.2% over the last six quarters.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 1.5% in the quarter ended Jun 30, 2021, against a decline of 18.7% in the quarter ended Dec 31, 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.97 billion (quarter ended Dec 31, 2025), $4.11 billion (quarter ended Sep 30, 2025) and $4.32 billion (quarter ended Jun 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Lakefront Biotherapeutics | 1.95 Bn | 1.95 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.95 Bn |
| Dec 31, 2025 | 3.97 Bn |
| Sep 30, 2025 | 4.11 Bn |
| Jun 30, 2025 | 4.32 Bn |
| Mar 31, 2025 | 4.23 Bn |
| Dec 31, 2024 | 4.42 Bn |
| Sep 30, 2024 | 4.58 Bn |
| Mar 31, 2024 | 4.74 Bn |
| Dec 31, 2023 | 4.69 Bn |
| Sep 30, 2023 | 4.85 Bn |
| Mar 31, 2023 | 4.97 Bn |
| Dec 31, 2022 | 4.83 Bn |
| Mar 31, 2022 | 5.72 Bn |
| Dec 31, 2021 | 5.94 Bn |
| Jun 30, 2021 | 6.54 Bn |
| Dec 31, 2020 | 6.82 Bn |
| Jun 30, 2020 | 6.45 Bn |
| Mar 31, 2020 | 6.62 Bn |
| Dec 31, 2019 | 6.72 Bn |
| Sep 30, 2019 | 6.51 Bn |
API Access
Lakefront Biotherapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LKFT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "LKFT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LKFT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();